Relationship of early-onset baldness to prostate cancer in African-American men
- PMID: 23532004
- PMCID: PMC3617056
- DOI: 10.1158/1055-9965.EPI-12-0944
Relationship of early-onset baldness to prostate cancer in African-American men
Abstract
Background: Early-onset baldness has been linked to prostate cancer; however, little is known about this relationship in African-Americans who are at elevated prostate cancer risk.
Methods: We recruited 219 African-American controls and 318 African-American prostate cancer cases. We determined age-stratified associations of baldness with prostate cancer occurrence and severity defined by high stage (T3/T4) or high grade (Gleason 7+.) Associations of androgen metabolism genotypes (CYP3A4, CYP3A5, CYP3A43, AR-CAG, SRD5A2 A49T, and SRD5A2 V89L), family history, alcohol intake, and smoking were examined by baldness status and age group by using multivariable logistic regression models.
Results: Baldness was associated with odds of prostate cancer [OR = 1.69; 95% confidence interval (CI), 1.05-2.74]. Frontal baldness was associated with high-stage (OR = 2.61; 95% CI, 1.10-6.18) and high-grade (OR = 2.20; 95% CI, 1.05-4.61) tumors. For men diagnosed less than the age of 60 years, frontal baldness was associated with high stage (OR = 6.51; 95% CI, 2.11-20.06) and high grade (OR = 4.23; 95% CI, 1.47-12.14). We also observed a suggestion of an interaction among smoking, median age, and any baldness (P = 0.02).
Conclusions: We observed significant associations between early-onset baldness and prostate cancer in African-American men. Interactions with age and smoking were suggested in these associations. Studies are needed to investigate the mechanisms influencing the relationship between baldness and prostate cancer in African-American men.
Impact: African-American men present with unique risk factors including baldness patterns that may contribute to prostate cancer disparities.
Conflict of interest statement
There are no conflicts of interest to disclose by any of the authors responsible for this study.
Similar articles
-
Early onset baldness and prostate cancer risk.Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):325-8. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10750672
-
Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):143-150. doi: 10.1158/1055-9965.EPI-23-0908. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 37851110
-
Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.Cancer Causes Control. 2018 Jan;29(1):93-102. doi: 10.1007/s10552-017-0981-0. Epub 2017 Nov 14. Cancer Causes Control. 2018. PMID: 29139043
-
CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review.Am J Epidemiol. 2004 Nov 1;160(9):825-41. doi: 10.1093/aje/kwh294. Am J Epidemiol. 2004. PMID: 15496535 Review.
-
African-American Prostate Cancer Disparities.Curr Urol Rep. 2017 Aug 14;18(10):81. doi: 10.1007/s11934-017-0724-5. Curr Urol Rep. 2017. PMID: 28808871 Review.
Cited by
-
Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study.Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1229-1236. doi: 10.1158/1055-9965.EPI-19-1236. Epub 2020 Apr 10. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32277004 Free PMC article.
-
Androgen metabolism genes in prostate cancer health disparities.Cancer Health Disparities. 2017;1:e1-e6. doi: 10.9777/rr.2017.10003. Epub 2017 Nov 18. Cancer Health Disparities. 2017. PMID: 30756097 Free PMC article.
-
Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.Prostate. 2015 Mar 1;75(4):415-23. doi: 10.1002/pros.22927. Epub 2014 Dec 9. Prostate. 2015. PMID: 25492530 Free PMC article.
-
PCaLiStDB: a lifestyle database for precision prevention of prostate cancer.Database (Oxford). 2020 Jan 1;2020:baz154. doi: 10.1093/database/baz154. Database (Oxford). 2020. PMID: 31950190 Free PMC article.
-
Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2018 Jul;97(28):e11379. doi: 10.1097/MD.0000000000011379. Medicine (Baltimore). 2018. PMID: 29995779 Free PMC article.
References
-
- Silverberg E, Lubera J. Cancer Statistics-1989. Ca A Cancer J for Clinicians. 1989;39:3–20. - PubMed
-
- Ernster V, Winkelstein W, Selvin S. Cohort mortality for prostatic cancer among non-whites. Science. 1978;200(4346):1165–6. - PubMed
-
- Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975–2007. Bethesda, MD: 2010. Available from: http://seer.cancer.gov/csr/1975_2007/
-
- Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute; Bethesda, MD: 2011. http://seer.cancer.gov/csr/1975_2008/ based on November 2010 SEER data submission]
-
- Powell I, Heilbrun L, Sakr W, Grignon D, Montie J, Novallo M, et al. The predictive value of race as a clinical prognostic facotr among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins. Urology. 1997;49(5):726–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials